Ophthalmology · San Juan, PR
NPI
1780652826
Since 2006
Specialty
Ophthalmology
Code 207W00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
611 Calle Pavia, Suite 210
San Juan, PR, 00909
Phone (787) 728-2318
Groups this clinician bills Medicare through
Medicare paid, 2024
$39K
661 services
Medicare patients, 2024
165
Average age 77
Drug cost, 2024
$959K
7,623 prescriptions
Company payments, 2025
$35.99
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Marino Blasini-Torres was code 92012 (ophthalmological e&m), 196 times for 115 patients. In total Marino Blasini-Torres billed 661 services in 27 codes, and Medicare paid $39K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-02-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 92012 Ophthalmological E&M | Office | 196 | 115 | $58.04 | $11K |
| 92133 Computerized Ophthalmic Imaging | Office | 99 | 93 | $22.76 | $2,253 |
| 92250 Angiography | Office | 84 | 83 | $21.85 | $1,835 |
| 92083 Vision, Hearing, and Speech Services | Office | 63 | 60 | $43.65 | $2,750 |
| 92134 Computerized Ophthalmic Imaging | Office | 61 | 58 | $25.18 | $1,536 |
| 92014 Ophthalmological E&M | Office | 33 | 32 | $77.31 | $2,551 |
| 92020 Ophthalmological E&M | Office | 29 | 22 | $17.53 | $508 |
| 92004 Ophthalmological E&M | Office | 15 | 15 | $88.14 | $1,322 |
| 76514 Ultrasound - Nonspecific | Office | 12 | 12 | $6.93 | $83.15 |
By year: 2022 $38K for 652 services; 2023 $39K for 719 services; 2024 $39K for 661 services.
Medicare prescription drug claims, 2024
In 2024, the drug Marino Blasini-Torres prescribed most often to Medicare patients was Lumigan (Bimatoprost), with 1,214 prescriptions and refills. In total Marino Blasini-Torres wrote 7,623 Medicare prescriptions that cost $959K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Lumigan Bimatoprost | 1,214 | 1,406 | 213 | $328K |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 923 | 1,660 | 223 | $31K |
| Latanoprost Generic | 895 | 1,184 | 177 | $13K |
| Brimonidine Tartrate Generic | 589 | 679 | 112 | $27K |
| Dorzolamide Hcl Generic | 435 | 657 | 104 | $14K |
| Alphagan P Brimonidine Tartrate | 402 | 437 | 81 | $88K |
| Vyzulta Latanoprostene Bunod | 319 | 337 | 60 | $83K |
| Carteolol Hcl Generic | 298 | 341 | 60 | $5,598 |
| Prednisolone Acetate Generic | 288 | 317 | 148 | $11K |
| Timolol Maleate Generic | 215 | 280 | 52 | $9,391 |
| Ketorolac Tromethamine Generic | 173 | 252 | 100 | $7,644 |
| Brimonidine Tartrate-Timolol Brimonidine Tartrate/Timolol | 155 | 177 | 28 | $20K |
| Travoprost Generic | 142 | 167 | 24 | $18K |
| Ciprofloxacin Hcl Generic | 129 | 134 | 95 | $1,528 |
| Polymyxin B Sul-Trimethoprim Polymyxin B Sulf/Trimethoprim | 125 | 251 | 97 | $1,477 |
Brand drugs: 3,664 claims; generic drugs: 3,959 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Marino Blasini-Torres $35.99 ($35.99 in general payments such as food, travel and fees) from 2 companies. The largest payer was Abbvie Inc. with $20.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.